562-43-6 Usage
Uses
Used in Pharmaceutical Industry:
Valeric acid, 2,3-dihydroxy-3-methyl-, is utilized as a precursor in the synthesis of various organic compounds, which can be further developed into pharmaceuticals. Its unique structure allows it to be a key component in the creation of new drugs with potential therapeutic properties.
Used in Chemical Synthesis:
In the chemical industry, valeric acid, 2,3-dihydroxy-3-methyl-, serves as a building block for the synthesis of a range of organic compounds. Its functional groups make it a versatile intermediate in the production of specialty chemicals, including those used in the fragrance, flavor, and pharmaceutical sectors.
Used in Research and Development:
valeric acid, 2,3-dihydroxy-3-methylis also used in research settings to explore its potential as a therapeutic agent. Ongoing studies are investigating its properties and effects, which could lead to new applications in medicine and other fields.
Used in Cosmetics Industry:
Given its natural origin and unique chemical structure, valeric acid, 2,3-dihydroxy-3-methyl-, may also find applications in the cosmetics industry, potentially serving as an ingredient in formulations that require natural, bioactive components.
Check Digit Verification of cas no
The CAS Registry Mumber 562-43-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 562-43:
(5*5)+(4*6)+(3*2)+(2*4)+(1*3)=66
66 % 10 = 6
So 562-43-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H12O4/c1-3-6(2,10)4(7)5(8)9/h4,7,10H,3H2,1-2H3,(H,8,9)
562-43-6Relevant articles and documents
Construction of an L-isoleucine overproducing strain of Escherichia coli K-12
Hashiguchi, Ken-Ichi,Takesada, Hiroko,Suzuki, Eiichiro,Matsui, Hiroshi
, p. 672 - 679 (2007/10/03)
The genes for a threonine deaminase that is resistant to feedback inhibition by L-isoleucine and for an active acetohydroxyacid synthase II were introduced by a plasmid into a L-threonine-producing recombinant strain of Escherichia coli K-12. Analysis of culture broth of the strain using 13C nuclear magnetic resonance suggested that α, β-dihydroxy-β-methylvalerate (DHMV) and α-keto-βmethylvalerate (KMV), the third and the fourth intermediates in the L-isoleucine biosynthetic pathway from L-threonine, respectively, accumulated in the medium in amounts comparable to that of L-isoleucine. The ratio of accumulated L-isoleucine:DHMV:KMV were approximately 2:1:1. The concentration of accumulated L-isoleucine increased by twofold after the additional introduction of the genes for dihyroxyacid dehydratase (DH) and transaminase-B (TA-B), and the intermediates no longer accumulated. The resultant strain TVD5 accumulated 10 g/1 of L-isoleucine from 40 g/1 of glucose.
